Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): A trial of the Eastern Cooperative Oncology Group

Kristen K. Ciombor*, Yang Feng, Al Bowen Benson, Yingjun Su, Linda Horton, Sarah P. Short, John Sae Wook Kauh, Charles Staley, Mary Mulcahy, Mark Powell, Katayoun I. Amiri, Ann Richmond, Jordan Berlin

*Corresponding author for this work

Research output: Contribution to journalArticle

16 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): A trial of the Eastern Cooperative Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences